换一批
换一批A lethally irradiated allogeneic granulocyte-macrophage colony stimulating factor-secreting tumor vaccine for pancreatic adenocarcinoma. A Phase II trial of safety, efficacy, and immune activation.
第一作者：
Eric,Lutz
第一单位：
Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.
作者：
主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗原, 肿瘤(Antigens, Neoplasm);癌症疫苗(Cancer Vaccines);癌, 胰腺管(Carcinoma, Pancreatic Ductal);细胞系, 肿瘤(Cell Line, Tumor);综合疗法(Combined Modality Therapy);无病生存(Disease-Free Survival);女(雌)性(Female);GPI连接蛋白质类(GPI-Linked Proteins);粒细胞巨噬细胞集落刺激因子(Granulocyte-Macrophage Colony-Stimulating Factor);人类(Humans);超敏反应, 迟发型(Hypersensitivity, Delayed);免疫疗法(Immunotherapy);男(雄)性(Male);中年人(Middle Aged);胰腺肿瘤(Pancreatic Neoplasms);存活率(Survival Rate);T淋巴细胞(T-Lymphocytes);转染(Transfection)
DOI
10.1097/SLA.0b013e3181fd271c
PMID
21217520
发布时间
2022-04-08
- 浏览39
Annals of surgery
328-35页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
